Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
19501
Extraction time and mustard concentration for extraction of aquatic oligochaetes by using wet funnel
Published 2025“…In Exp. S1.2, a fresh volume of approximately 100 cc of stock soil which had been collected from the same station was used because the original stock soil sample had already been depleted at that point. …”
-
19502
Table_3_Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.DOC
Published 2018“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
-
19503
Propagation of GABA-induced hyperpolarization at the axon regulates AP generation.
Published 2014“…Right, group data showing a decrease in the mean frequency of APs after GABA iontophoresis at the axon trunk. **, P<0.01, paired t-test. …”
-
19504
The effect of (+)-pentazocine and H<sub>2</sub>O<sub>2</sub> on ONHAs viability.
Published 2017“…At the highest concentration of PTZ (50μM), there was a trend toward decrease in viability that was not significant. …”
-
19505
Table_2_Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.doc
Published 2018“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
-
19506
Table_1_Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.doc
Published 2018“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
-
19507
Image_1_Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.TIF
Published 2018“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
-
19508
Image_1_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.TIF
Published 2018“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
-
19509
Table_2_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.doc
Published 2018“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
-
19510
Table_1_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.doc
Published 2018“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
-
19511
Table_3_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.DOC
Published 2018“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
-
19512
Image_2_N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.TIF
Published 2018“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
-
19513
Image_2_Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.TIF
Published 2018“…Characteristically, PEA acquired per se antinociceptive properties in tolerant animals, suggesting the possibility of an integrated morphine/PEA treatment protocol. To maintain a significant analgesia, morphine dose had to be increased from 5 up to 100 mg/kg over 17 days of daily treatment. …”
-
19514
Metabolic and Behavioral Compensations in Response to Caloric Restriction: Implications for the Maintenance of Weight Loss
Published 2009“…</p><h3>Conclusions</h3><p>For the first time we show that in free-living conditions, CR results in a metabolic adaptation and a behavioral adaptation with decreased physical activity levels. …”
-
19515
Piwi dissociates from mitotic nuage at the central spindle in a <i>klp10A</i>-dependent manner.
Published 2020“…Open arrowheads (D) point to a Piwi-positive nuage particle, sliding along and later releasing the MT bundle, without decreasing GFP-Piwi signal. …”
-
19516
52-Week Efficacy and Safety of Telbivudine with Conditional Tenofovir Intensification at Week 24 in HBeAg-Positive Chronic Hepatitis B
Published 2013“…<div><h3>Background and Aims</h3><p>The Roadmap concept is a therapeutic framework in chronic hepatitis B for the intensification of nucleoside analogue monotherapy based on early virologic response. …”
-
19517
Efficacy of combined interventions including preventative NPIs (e.g., masking, distancing, lockdowns) and testing and isolation.
Published 2021“…Moves can maintain NPI intensity with a less sensitive test (thick arrows), decrease NPI intensity with the same test (medium arrows), and decrease NPI intensity with a less sensitive test (light arrows). …”
-
19518
Supplementary file 1_Persistent burden and health inequalities of disease in women of childbearing age attributable to Intimate Partner Violence, 1990–2021.docx
Published 2025“…The IPV-attributable ASMR decreased from 2.61 per 100,000 population in 1990 (95% UI: 1.73 to 3.71) to 2.26 per 100,000 population in 2021 (95% UI: 1.45 to 3.21), with AAPC of -0.46 (95% CI: -0.60 to -0.33). …”
-
19519
Neurons from Kidins220<sup>−/−</sup> mice showed normal post-tetanic potentiation and synaptic depression of evoked EPSCs.
Published 2013“…The increase of the EPSC1 amplitude (arrows) is connected to a decrease of the paired-pulse ratio. Holding potential −86 mV. …”
-
19520
Some primate species encode a CD4 that functions as an entry receptor for an early isolate of HIV-1.
Published 2019“…Values above error bars represent fold decrease in viral entry relative to human CD4, only indicated for those samples that passed significance thresholds (one-way ANOVA for repeated measures effect, Dunnett’s test; <i>P</i> < 0.05). …”